Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 4 days agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
Novavax seeks FDA approval for updated Covid-19 vaccine
Pharmaceutical Technology via Yahoo Finance· 2 days agoNovavax has submitted an application to the US Food and Drug Administration (FDA) seeking approval...
Controversy erupts as Kansas AG Kobach slams Pfizer's 'misleading' vaccine marketing
The Raw Story· 1 day agoTOPEKA — Attorney General Kris Kobach filed a civil lawsuit Monday against pharmaceutical company...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 5 days agoThey have tips on what you need to know this season. (Getty Images) Vera Vita via Getty Images It’s...
Naomi Klein says yoga teachers and ‘white wealthy’ fitness gurus are fuelling vaccine scepticism
The Independent via Yahoo News· 7 days agoShe goes on the say that it is gym and yoga classes that are primarily playing into conspiracy...
Gateway - Quartz
Quartz· 7 hours agoPharma giant AstraZeneca aims to increase its revenue by a whopping 75% in 2030, up from the $45.8 billion it generated in 2023 — just as it pulls its COVID-19< ...
China’s Secondary Schools Are Not Equal
Foreign Policy Magazine· 2 hours agoThe highlights this week: A Chinese vocational student places in a global math competition against the odds, Chinese Premier Li Qiang makes a trip to...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 4 days agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
COVID/Flu Experimental Vaccine Receives Positive R | Newswise
Newswise· 2 days agoA vaccine that could offer protection against COVID-19 and the flu has received positive results during trials.According ...
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 5 days agoThe double-blinded, randomised trial will compare CVXGA's efficacy, safety, and immunogenicity...
